Arkolith/Insider Trading/STSA/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerSatsuma Pharmaceuticals, Inc. (STSA) · full profile →Form 4 · filed Apr 5, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2021Other(J)192K$5.91$1.1M5.3M
Apr 1, 2021Other(J)566K$5.91$3.3M566K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-046614) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML